| Code | Description | Claims | Beneficiaries | Total Paid |
| 0450 |
Emergency room services |
61,762 |
54,222 |
$6.41M |
| G9002 |
Coordinated care fee, maintenance rate |
13,535 |
13,479 |
$4.21M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,143 |
4,984 |
$993K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
11,145 |
9,837 |
$847K |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,719 |
7,424 |
$827K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,640 |
11,809 |
$522K |
| 80053 |
Comprehensive metabolic panel |
45,251 |
41,093 |
$521K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
4,251 |
4,108 |
$511K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
5,774 |
5,441 |
$504K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
22,326 |
20,064 |
$500K |
| 71045 |
Radiologic examination, chest; single view |
20,792 |
19,554 |
$383K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
12,142 |
10,941 |
$346K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,765 |
3,563 |
$337K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
48,958 |
43,843 |
$335K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,032 |
2,951 |
$335K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
5,645 |
5,444 |
$322K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,564 |
5,313 |
$285K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,909 |
1,846 |
$276K |
| 99199 |
Unlisted special service, procedure or report |
6,780 |
6,076 |
$220K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,535 |
7,849 |
$218K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
5,219 |
4,981 |
$206K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
5,358 |
4,500 |
$190K |
| 84484 |
|
16,075 |
12,476 |
$184K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,021 |
981 |
$183K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,130 |
3,588 |
$174K |
| 93970 |
|
1,481 |
1,439 |
$168K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,617 |
1,571 |
$154K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,276 |
3,059 |
$131K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,446 |
2,631 |
$123K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
8,569 |
8,073 |
$116K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
893 |
887 |
$112K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,331 |
2,277 |
$112K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,297 |
2,202 |
$111K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
590 |
571 |
$110K |
| 80306 |
|
6,518 |
5,047 |
$109K |
| 93971 |
|
1,132 |
1,099 |
$100K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,662 |
4,289 |
$91K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,550 |
1,617 |
$81K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,632 |
1,541 |
$78K |
| 83605 |
|
9,220 |
8,048 |
$72K |
| 83880 |
|
3,971 |
3,672 |
$69K |
| 87040 |
|
6,012 |
3,949 |
$68K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,941 |
8,257 |
$68K |
| 0300 |
|
1,239 |
1,035 |
$68K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
7,967 |
7,525 |
$66K |
| 85610 |
|
15,184 |
14,126 |
$65K |
| J3490 |
Unclassified drugs |
14,955 |
11,273 |
$65K |
| 83690 |
|
11,056 |
10,272 |
$64K |
| 76830 |
Ultrasound, transvaginal |
1,230 |
1,179 |
$61K |
| 0250 |
|
8,019 |
6,461 |
$54K |
| 76801 |
|
887 |
752 |
$48K |
| 0259 |
|
7,834 |
5,129 |
$48K |
| 0270 |
|
7,240 |
5,133 |
$47K |
| Z7502 |
|
1,277 |
1,253 |
$47K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,929 |
1,084 |
$46K |
| 84703 |
|
7,662 |
7,155 |
$46K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,674 |
2,226 |
$42K |
| 73630 |
|
1,548 |
1,432 |
$39K |
| 81001 |
|
14,051 |
13,261 |
$39K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
914 |
890 |
$39K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,082 |
8,209 |
$36K |
| 84145 |
|
2,916 |
2,780 |
$33K |
| 76942 |
|
801 |
698 |
$33K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
668 |
651 |
$33K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
5,836 |
5,117 |
$31K |
| 0160 |
|
974 |
710 |
$31K |
| 72131 |
|
191 |
188 |
$31K |
| 81003 |
|
12,776 |
12,017 |
$31K |
| 84702 |
|
3,358 |
3,051 |
$30K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
634 |
550 |
$30K |
| 90715 |
|
954 |
932 |
$29K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,715 |
2,460 |
$29K |
| 73610 |
|
1,202 |
1,121 |
$29K |
| 85730 |
|
5,161 |
4,985 |
$27K |
| 73030 |
|
1,208 |
1,130 |
$27K |
| 73130 |
|
1,025 |
931 |
$26K |
| 96367 |
|
862 |
828 |
$26K |
| 0272 |
|
1,464 |
1,346 |
$26K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,899 |
5,366 |
$25K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,471 |
3,214 |
$25K |
| 70486 |
|
251 |
247 |
$24K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,392 |
2,309 |
$23K |
| 86850 |
|
2,785 |
2,657 |
$22K |
| 71250 |
|
259 |
252 |
$22K |
| 94762 |
|
1,318 |
1,204 |
$22K |
| 0949 |
|
170 |
109 |
$21K |
| Z7500 |
|
584 |
504 |
$20K |
| 82948 |
|
3,227 |
1,940 |
$20K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,323 |
1,214 |
$19K |
| 83735 |
|
3,225 |
2,852 |
$19K |
| 74174 |
|
132 |
132 |
$19K |
| 71046 |
Radiologic examination, chest; 2 views |
802 |
788 |
$19K |
| 85379 |
|
2,172 |
2,110 |
$17K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,354 |
1,301 |
$17K |
| 86140 |
|
3,284 |
3,117 |
$17K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
872 |
854 |
$16K |
| 76770 |
|
237 |
227 |
$16K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,269 |
1,229 |
$16K |
| 87186 |
|
2,006 |
1,872 |
$16K |
| G0378 |
Hospital observation service, per hour |
349 |
242 |
$16K |
| 86900 |
|
3,544 |
3,346 |
$15K |
| 80047 |
|
2,136 |
2,021 |
$15K |
| 93975 |
|
124 |
123 |
$15K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,784 |
1,711 |
$14K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
228 |
227 |
$14K |
| 0762 |
|
99 |
53 |
$13K |
| 73564 |
|
382 |
352 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
12,497 |
11,054 |
$13K |
| 72100 |
|
428 |
421 |
$12K |
| 86141 |
|
1,812 |
1,728 |
$12K |
| 82550 |
|
2,670 |
2,480 |
$12K |
| 81002 |
|
5,026 |
4,628 |
$11K |
| 87581 |
|
617 |
590 |
$11K |
| 81025 |
|
2,733 |
2,527 |
$11K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,850 |
1,443 |
$11K |
| 87486 |
|
618 |
591 |
$11K |
| 86901 |
|
3,484 |
3,293 |
$11K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
627 |
596 |
$10K |
| 0710 |
|
348 |
320 |
$10K |
| 94760 |
|
1,352 |
1,214 |
$10K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
319 |
301 |
$10K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
768 |
741 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
767 |
740 |
$10K |
| 70498 |
|
122 |
121 |
$10K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
1,084 |
900 |
$9K |
| 74018 |
|
539 |
511 |
$9K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,225 |
2,038 |
$9K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
98 |
93 |
$9K |
| 99000 |
|
3,150 |
2,943 |
$9K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,044 |
993 |
$9K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,175 |
1,141 |
$9K |
| 96376 |
|
2,458 |
2,177 |
$8K |
| 73562 |
|
353 |
307 |
$8K |
| 86769 |
|
183 |
145 |
$8K |
| J2060 |
Injection, lorazepam, 2 mg |
2,012 |
1,767 |
$8K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
1,144 |
1,053 |
$7K |
| 70496 |
|
69 |
69 |
$7K |
| 73560 |
|
417 |
363 |
$7K |
| 80050 |
General health panel |
594 |
585 |
$6K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,075 |
1,033 |
$6K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
13 |
13 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
755 |
703 |
$6K |
| 84439 |
|
964 |
941 |
$6K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,796 |
1,669 |
$6K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
41 |
41 |
$6K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
183 |
170 |
$6K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
75 |
55 |
$6K |
| 87077 |
|
1,191 |
1,100 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
524 |
514 |
$5K |
| 27502 |
|
20 |
18 |
$5K |
| 36430 |
|
76 |
58 |
$5K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
379 |
366 |
$5K |
| J1815 |
Injection, insulin, per 5 units |
190 |
136 |
$5K |
| 80061 |
Lipid panel |
567 |
558 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,202 |
1,163 |
$4K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
749 |
721 |
$4K |
| 85652 |
|
1,368 |
1,303 |
$4K |
| 99070 |
|
256 |
169 |
$4K |
| 97010 |
|
183 |
76 |
$3K |
| 87081 |
|
737 |
709 |
$3K |
| 85014 |
|
2,035 |
1,925 |
$3K |
| A4649 |
Surgical supply; miscellaneous |
1,729 |
1,243 |
$3K |
| 87088 |
|
720 |
689 |
$3K |
| 82728 |
|
304 |
277 |
$3K |
| 0271 |
|
572 |
522 |
$3K |
| 73590 |
|
146 |
134 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
632 |
621 |
$3K |
| 76870 |
|
52 |
52 |
$2K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
119 |
108 |
$2K |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
336 |
305 |
$2K |
| 73502 |
|
85 |
81 |
$2K |
| 0320 |
|
186 |
175 |
$2K |
| 97163 |
|
52 |
52 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
392 |
357 |
$2K |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
69 |
67 |
$2K |
| 73090 |
|
68 |
67 |
$1K |
| 84100 |
|
457 |
425 |
$1K |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
1,155 |
1,053 |
$1K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
13 |
13 |
$1K |
| 73110 |
|
70 |
65 |
$1K |
| E0112 |
Crutches underarm, wood, adjustable or fixed, pair, with pads, tips and handgrips |
123 |
120 |
$1K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
183 |
163 |
$1K |
| 86308 |
|
328 |
326 |
$1K |
| 83615 |
|
224 |
215 |
$1K |
| 80320 |
|
756 |
667 |
$989.95 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
118 |
113 |
$977.62 |
| 99001 |
|
95 |
90 |
$954.88 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
220 |
202 |
$953.54 |
| 0510 |
|
346 |
275 |
$865.83 |
| 71010 |
|
75 |
27 |
$863.62 |
| 87205 |
|
370 |
338 |
$849.62 |
| J2704 |
Injection, propofol, 10 mg |
108 |
84 |
$804.29 |
| J3486 |
Injection, ziprasidone mesylate, 10 mg |
14 |
12 |
$776.80 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
12 |
12 |
$761.80 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
299 |
278 |
$710.73 |
| 74021 |
|
17 |
17 |
$703.90 |
| 80076 |
|
124 |
120 |
$648.46 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
378 |
357 |
$541.82 |
| 72040 |
|
41 |
39 |
$522.98 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
97 |
93 |
$494.09 |
| 0636 |
|
64 |
55 |
$445.90 |
| 86923 |
|
13 |
12 |
$439.42 |
| 82803 |
|
48 |
44 |
$429.30 |
| 85027 |
|
121 |
115 |
$426.87 |
| 85007 |
|
190 |
172 |
$408.74 |
| 73100 |
|
29 |
25 |
$381.04 |
| 87420 |
|
143 |
139 |
$370.18 |
| 82330 |
|
45 |
41 |
$359.21 |
| 0258 |
|
79 |
57 |
$327.96 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
176 |
152 |
$321.58 |
| 73140 |
|
25 |
25 |
$307.93 |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
12 |
12 |
$258.91 |
| J1644 |
Injection, heparin sodium, per 1000 units |
120 |
69 |
$244.22 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
298 |
285 |
$240.09 |
| J1630 |
Injection, haloperidol, up to 5 mg |
77 |
68 |
$234.49 |
| 84436 |
|
114 |
114 |
$222.23 |
| Z7610 |
|
32 |
26 |
$214.27 |
| J3360 |
Injection, diazepam, up to 5 mg |
48 |
46 |
$198.14 |
| 76937 |
|
14 |
12 |
$163.27 |
| 94644 |
|
20 |
18 |
$157.89 |
| 84295 |
|
44 |
41 |
$153.82 |
| J0456 |
Injection, azithromycin, 500 mg |
31 |
24 |
$153.59 |
| 84132 |
|
44 |
41 |
$152.40 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
251 |
238 |
$140.94 |
| S0028 |
Injection, famotidine, 20 mg |
74 |
69 |
$127.22 |
| 82947 |
|
44 |
41 |
$125.63 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
81 |
77 |
$124.43 |
| 87210 |
|
28 |
26 |
$105.09 |
| 82010 |
|
39 |
37 |
$99.31 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
174 |
165 |
$89.22 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
19 |
18 |
$72.41 |
| 82150 |
|
28 |
28 |
$67.71 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
95 |
89 |
$62.61 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
13 |
12 |
$55.87 |
| J7510 |
Prednisolone oral, per 5 mg |
42 |
42 |
$47.88 |
| 82570 |
|
31 |
27 |
$47.42 |
| 87147 |
|
13 |
12 |
$34.56 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
39 |
37 |
$28.03 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
26 |
26 |
$27.06 |
| 82607 |
|
12 |
12 |
$26.84 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
25 |
21 |
$14.10 |
| 96379 |
|
19 |
19 |
$0.00 |
| 0301 |
|
19 |
17 |
$0.00 |
| 80349 |
|
28 |
27 |
$0.00 |
| 90686 |
|
13 |
13 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$0.00 |